BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15747262)

  • 1. Preoperative use of enoxaparin increases the risk of postoperative bleeding and re-exploration in cardiac surgery patients.
    McDonald SB; Renna M; Spitznagel EL; Avidan M; Hogue CW; Moon MR; Barzilai B; Saleem R; McDonald JM; Despotis GJ
    J Cardiothorac Vasc Anesth; 2005 Feb; 19(1):4-10. PubMed ID: 15747262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome: clinical investigation and reports.
    Jones HU; Muhlestein JB; Jones KW; Bair TL; Lavasani F; Sohrevardi M; Horne BD; Doty D; Lappe DL
    Circulation; 2002 Sep; 106(12 Suppl 1):I19-22. PubMed ID: 12354703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early postoperative use of unfractionated heparin or enoxaparin is associated with increased surgical re-exploration for bleeding.
    Jones HU; Muhlestein JB; Jones KW; Renlund DG; Bair TL; Bunch TJ; Horne BD; Lappé DL; Anderson JL; Doty DB
    Ann Thorac Surg; 2005 Aug; 80(2):518-22. PubMed ID: 16039196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements.
    Filsoufi F; Rahmanian PB; Castillo JG; Kahn RA; Fischer G; Adams DH
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):60-6. PubMed ID: 18249332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: impact of discontinuation prior to surgery.
    Maltais S; Perrault LP; Do QB
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):127-31. PubMed ID: 18455412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fondaparinux or enoxaparin: a comparative study of postoperative bleeding in coronary artery bypass grafting surgery.
    Landenhed M; Johansson M; Erlinge D; Olsson ML; Bjursten H
    Scand Cardiovasc J; 2010 Apr; 44(2):100-6. PubMed ID: 19961287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery.
    Kang W; Theman TE; Reed JF; Stoltzfus J; Weger N
    J Surg Educ; 2007; 64(2):88-92. PubMed ID: 17462208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.
    Reichert MG; Robinson AH; Travis JA; Hammon JW; Kon ND; Kincaid EH
    Pharmacotherapy; 2008 Feb; 28(2):151-5. PubMed ID: 18225962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae?
    Kapetanakis EI; Medlam DA; Petro KR; Haile E; Hill PC; Dullum MK; Bafi AS; Boyce SW; Corso PJ
    Circulation; 2006 Apr; 113(13):1667-74. PubMed ID: 16567570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial.
    Jolly SS; Faxon DP; Fox KA; Afzal R; Boden WE; Widimsky P; Steg PG; Valentin V; Budaj A; Granger CB; Joyner CD; Chrolavicius S; Yusuf S; Mehta SR
    J Am Coll Cardiol; 2009 Jul; 54(5):468-76. PubMed ID: 19628124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
    Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin.
    Ouattara A; Bouzguenda H; Le Manach Y; Léger P; Mercadier A; Leprince P; Bonnet N; Montalescot G; Riou B; Coriat P
    Eur Heart J; 2007 Apr; 28(8):1025-32. PubMed ID: 17431000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE).
    Brieger D; Van de Werf F; Avezum A; Montalescot G; Kennelly BM; Granger CB; Goodman SG; Dabbous OH; Agnelli G;
    Am Heart J; 2007 Jun; 153(6):960-9. PubMed ID: 17540196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel and bleeding after coronary artery bypass graft surgery.
    Leong JY; Baker RA; Shah PJ; Cherian VK; Knight JL
    Ann Thorac Surg; 2005 Sep; 80(3):928-33. PubMed ID: 16122457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
    White HD; Kleiman NS; Mahaffey KW; Lokhnygina Y; Pieper KS; Chiswell K; Cohen M; Harrington RA; Chew DP; Petersen JL; Berdan LG; Aylward PE; Nessel CC; Ferguson JJ; Califf RM
    Am Heart J; 2006 Dec; 152(6):1042-50. PubMed ID: 17161049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome.
    Ng FH; Wong SY; Lam KF; Chang CM; Lau YK; Chu WM; Wong BC
    Am J Gastroenterol; 2008 Apr; 103(4):865-71. PubMed ID: 18177451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
    Morrow DA; Antman EM; Murphy SA; Qin J; Ruda M; Guneri S; Jacob AJ; Budaj A; Braunwald E;
    Am Heart J; 2007 Dec; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.